2,336
Total Claims
$250K
Drug Cost
387
Beneficiaries
$645
Cost/Patient
Peer Comparison vs. 4,479 Interventional Cardiology providers
-39%
Cost per patient vs peers
$645 vs $1,054 avg
-10%
Brand preference vs peers
11.8% vs 13.1% avg
Brand vs Generic
88% generic
Brand: 275 claims · $212K
Generic: 2,061 claims · $38K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 85 | $85K |
| Empagliflozin | 44 | $40K |
| Rivaroxaban | 18 | $31K |
| Sacubitril/Valsartan | 19 | $25K |
| Ticagrelor | 23 | $15K |
| Metoprolol Succinate | 338 | $5,635 |
| Atorvastatin Calcium | 290 | $3,382 |
| Isosorbide Mononitrate | 130 | $1,707 |
| Clopidogrel Bisulfate | 107 | $1,570 |
| Ranolazine | 14 | $1,494 |
| Valsartan | 45 | $1,395 |
| Potassium Chloride | 84 | $1,288 |
| Warfarin Sodium | 46 | $1,240 |
| Furosemide | 209 | $1,182 |
| Carvedilol | 90 | $1,080 |
Prescribing Profile
32
Unique Drugs
$182K
Patient Profile
74
Avg Age
43%
Female
1.86
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About